Quality Control Co-op
Boost your chances before you apply.
Beam Therapeutics
Cambridge, MA, US
Summary
The co-op will provide operational and laboratory support to the Quality Control team, including reagent management and method lifecycle activities. They will also assist in documenting quality events and reviewing analytical data to ensure compliance with GMP standards.
Job Description
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is looking for a highly energetic co-op to join our growing quality control team. The co-op will provide operational, administrative, and laboratory support to the QC organization. This role is intended to support PLI readiness, method lifecycle activities, laboratory organization, reagent traceability, and quality-system-related activities while providing hands-on exposure to a GMP-regulated laboratory environment.
Responsibilities:
- Assist in procurement, tracking, and management of reagents and materials.
- Assist with method lifecycle activities, including feasibility runs and troubleshooting of analytical methods and laboratory instruments under supervision.
- Organize, document and archive historical data sets.
- Support quality event documentation (e.g., Deviation, CAPA, Change Control).
- Assist in reviewing data generated by other analysts to ensure accuracy and compliance.
- Learn about key functions in pharmaceutical development and manufacturing, including analytics, stability testing, manufacturing processes, and quality systems.
- Gain hands-on experience with analytical methods and techniques commonly used in the pharmaceutical and biotech industries.
Qualifications:
- Pursuing a BS or MS in biological sciences or a related field (Biochemistry/Biophysics, Cell Biology/Molecular Biology, Chemistry)
- Completed entry level biology, chemistry and biochemistry courses
- Completed of biology, chemistry and biochemistry lab courses.
- Knowledge of ICH/USP guidelines is highly desirable.
- Must be a team player, comfortable working collaboratively and thriving in a fast-paced environment.
- Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the co-op to be eligible.
Hourly pay will will be determined based on several factors, including but not limited to, relevant experience, skills, and education.
Co-op Hourly Pay Range$23—$34 USD
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.
Our dream is to provide life-long cures for patients suffering from serious diseases.
The Beam Team Is:
• A community of fearless innovators
• Rigorous and honest in our research
• Listening with open minds
• Committed to each other
Founded
2017
Company size
501-1,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Cambridge, Massachusetts
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.
Our dream is to provide life-long cures for patients suffering from serious diseases.
The Beam Team Is:
• A community of fearless innovators
• Rigorous and honest in our research
• Listening with open minds
• Committed to each other
Founded
2017
Company size
501-1,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Cambridge, Massachusetts